Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan I Silverberg

Showing results (291-300 of 667) with videos related to

Pageof 67
Sort By:
Skin Health and Disease|August 6, 2024
Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitisJonathan I Silverberg, Jacob P Thyssen, Irina Lazariciu, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Choice of new treatment for patients with atopic dermatitis is associated with insurance status rather than race: A cross sectional study from commercial and Medicaid insurance claims databasesMaria C Schneeweiss, Robert J Glynn, Priyanka Anand, et al.
JAMA Dermatology|December 24, 2014
Central obesity and high blood pressure in pediatric patients with atopic dermatitisJonathan I Silverberg, Lauren Becker, Mary Kwasny, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Burden and characteristics of skin pain among children with atopic dermatitisBrian T Cheng, Amy S Paller, James W Griffith, et al.
Archives of Dermatological Research|March 9, 2022
Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysisAlex M Rokni, Marissa Ayasse, Adnan Ahmed, et al.
Dermatology and Therapy|May 20, 2026
Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled AnalysisJonathan I Silverberg, Eric L Simpson, Saleem A Farooqui, et al.
Archives of Dermatological Research|June 8, 2024
Patient-reported burden in adults with atopic dermatitis: an international qualitative studyAndreas Wollenberg, Melinda Gooderham, Norito Katoh, et al.
Journal of Cutaneous Medicine and Surgery|April 12, 2026
The Atopic Dermatitis Shared Decision-Making Tool: Implementing the AHEAD Approach in Clinical PracticeAndreas Wollenberg, Melinda Gooderham, Norito Katoh, et al.
JAMA Pediatrics|December 6, 2016
Cost-effectiveness of Prophylactic Moisturization for Atopic DermatitisShuai Xu, Supriya Immaneni, Gordon B Hazen, et al.
Arthritis Care & Research|August 27, 2016
Validation of International Classification of Diseases Codes for the Epidemiologic Study of DermatomyositisMichael C Kwa, Kaveh Ardalan, Anne E Laumann, et al.
Pageof 67

Showing results (291-300 of 667) with videos related to

Sort By:
Pageof 67
Skin Health and Disease|August 6, 2024
Abrocitinib may improve itch and quality of life in patients with itch-dominant atopic dermatitisJonathan I Silverberg, Jacob P Thyssen, Irina Lazariciu, et al.
Journal of the American Academy of Dermatology|October 8, 2025
Choice of new treatment for patients with atopic dermatitis is associated with insurance status rather than race: A cross sectional study from commercial and Medicaid insurance claims databasesMaria C Schneeweiss, Robert J Glynn, Priyanka Anand, et al.
JAMA Dermatology|December 24, 2014
Central obesity and high blood pressure in pediatric patients with atopic dermatitisJonathan I Silverberg, Lauren Becker, Mary Kwasny, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 26, 2021
Burden and characteristics of skin pain among children with atopic dermatitisBrian T Cheng, Amy S Paller, James W Griffith, et al.
Archives of Dermatological Research|March 9, 2022
Association of autoimmune blistering disease, and specifically, pemphigus vulgaris, with cardiovascular disease and its risk factors: a systematic review and meta-analysisAlex M Rokni, Marissa Ayasse, Adnan Ahmed, et al.
Dermatology and Therapy|May 20, 2026
Efficacy and Safety of Variable-Dose Versus Continuous-Dose Abrocitinib Treatment in Patients with Moderate-to-Severe Atopic Dermatitis: A Pooled AnalysisJonathan I Silverberg, Eric L Simpson, Saleem A Farooqui, et al.
Archives of Dermatological Research|June 8, 2024
Patient-reported burden in adults with atopic dermatitis: an international qualitative studyAndreas Wollenberg, Melinda Gooderham, Norito Katoh, et al.
Journal of Cutaneous Medicine and Surgery|April 12, 2026
The Atopic Dermatitis Shared Decision-Making Tool: Implementing the AHEAD Approach in Clinical PracticeAndreas Wollenberg, Melinda Gooderham, Norito Katoh, et al.
JAMA Pediatrics|December 6, 2016
Cost-effectiveness of Prophylactic Moisturization for Atopic DermatitisShuai Xu, Supriya Immaneni, Gordon B Hazen, et al.
Arthritis Care & Research|August 27, 2016
Validation of International Classification of Diseases Codes for the Epidemiologic Study of DermatomyositisMichael C Kwa, Kaveh Ardalan, Anne E Laumann, et al.
Pageof 67